Lineage Cell Therapeutics Inc (LCTX)
1.10
-0.04
(-3.51%)
USD |
NYAM |
Apr 24, 16:00
1.11
+0.01
(+0.91%)
After-Hours: 20:00
Lineage Cell Therapeutics Shareholders Equity (Quarterly): 63.42M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 63.42M |
September 30, 2023 | 68.12M |
June 30, 2023 | 72.67M |
March 31, 2023 | 70.45M |
December 31, 2022 | 73.34M |
September 30, 2022 | 78.95M |
June 30, 2022 | 82.85M |
March 31, 2022 | 86.55M |
December 31, 2021 | 92.22M |
September 30, 2021 | 120.71M |
June 30, 2021 | 124.71M |
March 31, 2021 | 117.67M |
December 31, 2020 | 96.20M |
September 30, 2020 | 91.27M |
June 30, 2020 | 99.44M |
March 31, 2020 | 106.50M |
December 31, 2019 | 112.96M |
September 30, 2019 | 117.16M |
June 30, 2019 | 133.39M |
March 31, 2019 | 162.84M |
December 31, 2018 | 93.84M |
September 30, 2018 | 171.13M |
June 30, 2018 | 100.98M |
March 31, 2018 | 99.97M |
December 31, 2017 | 162.64M |
Date | Value |
---|---|
September 30, 2017 | 198.29M |
June 30, 2017 | 176.12M |
March 31, 2017 | 187.37M |
December 31, 2016 | 117.93M |
September 30, 2016 | 119.39M |
June 30, 2016 | 85.74M |
March 31, 2016 | 10.85M |
December 31, 2015 | 25.82M |
September 30, 2015 | 13.04M |
June 30, 2015 | 16.98M |
March 31, 2015 | 26.25M |
December 31, 2014 | 36.46M |
September 30, 2014 | 10.98M |
June 30, 2014 | 17.91M |
March 31, 2014 | 19.24M |
December 31, 2013 | 14.80M |
September 30, 2013 | 12.94M |
June 30, 2013 | 20.92M |
March 31, 2013 | 15.84M |
December 31, 2012 | 9.584M |
September 30, 2012 | 16.94M |
June 30, 2012 | 23.18M |
March 31, 2012 | 24.20M |
December 31, 2011 | 28.65M |
September 30, 2011 | 33.62M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
63.42M
Minimum
Dec 2023
133.39M
Maximum
Jun 2019
95.19M
Average
92.22M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
Acumen Pharmaceuticals Inc | 266.97M |
Sarepta Therapeutics Inc | 859.34M |
CEL-SCI Corp | 12.65M |
AIM ImmunoTech Inc | 10.23M |
IGC Pharma Inc | 9.053M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 101.02M |
Total Liabilities (Quarterly) | 39.00M |
Current Ratio | 2.140 |